Skip to main content

Solventum Corporation (SOLV) Receives a Buy from Piper Sandler

Tipranks - Tipranks - Wed Feb 25, 5:40AM CST

Piper Sandler analyst Jason Bednar maintained a Buy rating on Solventum Corporation today and set a price target of $98.00.

Claim 50% Off TipRanks Premium

According to TipRanks, Bednar is an analyst with an average return of -4.2% and a 41.55% success rate. Bednar covers the Healthcare sector, focusing on stocks such as Masimo, NovoCure, and Align Tech.

In addition to Piper Sandler, Solventum Corporation also received a Buy from BTIG’s Ryan Zimmerman in a report issued on February 18. However, on February 15, Bank of America Securities maintained a Hold rating on Solventum Corporation (NYSE: SOLV).

See Insiders’ Hot Stocks on TipRanks >>

Based on Solventum Corporation’s latest earnings release for the quarter ending September 30, the company reported a quarterly revenue of $2.1 billion and a net profit of $1.27 billion. In comparison, last year the company earned a revenue of $2.08 billion and had a net profit of $122 million

Read More on SOLV:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).